Status:
COMPLETED
Mycophenolate vs Azathioprin in Autoimmune Hepatitis
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Autoimmune Hepatitis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
A study with 20 de novo patients with autoimmune hepatitis, 10 receiving azathioprin and 10 receiving mycophenolat mofetil.
Eligibility Criteria
Inclusion
- De novo autoimmune hepatitis
- Consent
Exclusion
- age below 18
- pregnancy
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00687180
Last Update
May 30 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet, Dept. of Hepatology A-2121
Copenhagen, Denmark, 2100